Repare Therapeutics Inc. (RPTX) Financials

RPTX Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2025 126.7 million 11.6 million
June 30, 2025 130.5 million 20.1 million
March 31, 2025 144.0 million 18.9 million
Dec. 31, 2024 176.5 million 25.4 million

RPTX Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 2.7 million 1.4 million
June 30, 2025 -16.3 million 2.1 million
March 31, 2025 -29.1 million 4.0 million
Dec. 31, 2024 -27.3 million 4.9 million

RPTX Net Income

No data available :(

RPTX Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 112.6 million - 342000
June 30, 2025 109.5 million - 649000
March 31, 2025 124.2 million - 1.4 million
Dec. 31, 2024 152.8 million 88000 1.9 million

RPTX Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 43.1 million
June 30, 2025 42.9 million
March 31, 2025 42.6 million
Dec. 31, 2024 42.4 million

RPTX Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 - 7.5 million 4.5 million -
June 30, 2025 - 14.3 million 6.0 million -
March 31, 2025 - 18.9 million 7.7 million -
Dec. 31, 2024 - 24.4 million 5.8 million -

RPTX Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 11.6 million -
June 30, 2025 250000 1.0 million
March 31, 2025 - 1.2 million
Dec. 31, 2024 -53.5 million 454000

RPTX Revenue by Segment

Graph available only for paid members. Upgrade to see it.

RPTX

Price: $2.65

52 week price:
0.89
2.66

Earnings Per Share: -1.70 USD

P/E Ratio: -1.51

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 108000

Market Capitalization: 110.5 million

Links: